National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
Esophageal Cancer Treatment (PDQ®)     
Last Modified: 07/02/2009
Health Professional Version
Recurrent Esophageal Cancer

Current Clinical Trials

All recurrent esophageal cancer patients present difficult problems in palliation. All patients, whenever possible, should be considered candidates for clinical trials as outlined in treatment overview.

Standard treatment options:

  • Palliative use of any of the standard therapies, including supportive care.

Treatment options under clinical evaluation:

  • Clinical trials.
Current Clinical Trials

Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with recurrent esophageal cancer 1. The list of clinical trials can be further narrowed by location, drug, intervention, and other criteria.

General information about clinical trials is also available from the NCI Web site 2.


Table of Links

1http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?Diagnosis=43721&tt=1&a
mp;format=2&cn=1
2http://www.cancer.gov/clinicaltrials